Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor prodrugs activated by FAPalpha

Jan. 15, 2001

Inhibitors of growth factor receptor tyrosine kinases developed at BMS

Jan. 15, 2001

Sonus begins phase I evaluation of less toxic form of paclitaxel

Jan. 15, 2001

Sanofi-Synthelabo to market Leuprogel in the U.S. and Canada

Jan. 12, 2001

NCI and Biovest may enter B-cell lymphoma vaccine collaboration

Jan. 12, 2001

Preparation and use of cyclin-dependent kinase inhibitors

Jan. 11, 2001

Novel series from Pfizer for use in hyperproliferative conditions

Jan. 11, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Ilex submits IND to FDA for angiogenesis inhibitor NM-3

Jan. 11, 2001

AVI BioPharma receives grant to develop NeuGene-based prostate cancer therapeutics

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...